Evidence map›Paper›PMID 24266646›Full record

ArticleBiomacromolecules2013

The microstructure and bulk rheology of human cervicovaginal mucus are remarkably resistant to changes in pH.

Ying-Ying Wang, Samuel K Lai, Laura M Ensign, Weixi Zhong, Richard Cone, Justin Hanes

Open access · greenAbstract read
In one paragraph

Article in Biomacromolecules, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. The Known and Unknown About Female Reproductive Tract Mucus Rheological Properties.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  3. Hydrogels for Mucosal Drug Delivery.ACS applied bio materials · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Passive and Active Microrheology for Biomedical Systems.Frontiers in bioengineering and biotechnology · 2022
    Review
  8. Acupuncture for Female Infertility: Discussion on Action Mechanism and Application.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  9. Article
  10. The Cervicovaginal Mucus Barrier.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  16. Article
  17. Mucins and Their Role in Shaping the Functions of Mucus Barriers.Annual review of cell and developmental biology · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ying-Ying WangCenter for Nanomedicine, ‡Department of Biomedical Engineering, and §Department of Ophthalmology, Johns Hopkins University School of Medicine , Baltimore, Maryland 21231, United States.
Samuel K Lai
Laura M Ensign
Weixi Zhong
Richard Cone
Justin Hanes
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Duet cervical barrier device for maximizing protective efficacy of microbicidesU01AI066726 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CONE, RICHARD · 2005 to 2009
$2.0M
Pathogen trapping by genital mucus secretionsR01HD062844 · NICHD · JOHNS HOPKINS UNIVERSITY · PI CONE, RICHARD, HANES, JUSTIN S. · 2010 to 2014
$1.6M
Mucus-penetrating nanoparticles for sustained microbicide deliveryR33AI079740 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HANES, JUSTIN S. · 2010 to 2012
$1.4M
Mucus Penetrating Particles for Rectal MicrobicidesR33AI094519 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CONE, RICHARD, HANES, JUSTIN S. · 2013 to 2015
$1.4M
Mucus penetrating nanoparticles for early stage cervical cancerR01CA140746 · NCI · JOHNS HOPKINS UNIVERSITY · PI HANES, JUSTIN S. · 2009 to 2010
$665k
Mucus Penetrating Particles for Rectal MicrobicidesR21AI094519 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CONE, RICHARD, HANES, JUSTIN S. · 2011 to 2012
$440k
NCI NIH HHS 1R01CA140746NCI NIH HHS R01 CA140746NIAID NIH HHS 5U01AI066726NIAID NIH HHS R21 AI094519NIAID NIH HHS R33 AI079740NIAID NIH HHS R33 AI079740-01NIAID NIH HHS R33 AI094519NIAID NIH HHS U01 AI066726NICHD NIH HHS R01 HD062844NICHD NIH HHS R01HD062844
6 · The paper itself

Abstract

The protective barrier, lubricant, and clearance functions of mucus are intimately coupled to its microstructure and bulk rheology. Mucus gels consist of a network of mucin biopolymers along with lipids, salts, and other proteins and exhibit similar biochemical and physical properties across diverse mucosal surfaces. Nevertheless, mucus is exposed to a broad range of pH values throughout the human body. Protein functions are typically sensitive to small changes in pH, and prior investigations using reconstituted, purified mucin gels suggested mucus undergoes a transition from a low-viscosity liquid at neutral pH to a highly viscoelastic solid at low pH. We sought to determine whether those observations hold for fresh, minimally perturbed human mucus ex vivo by using different-sized muco-inert nanoparticles to probe microstructure and cone-and-plate rheometry to measure bulk rheology. We demonstrate that both the microstructure and bulk rheology of fresh, undiluted, and minimally perturbed cervicovaginal mucus exhibit relatively minor changes from pH 1-2 to 8-9, in marked contrast with the pH sensitivity of purified mucin gels. Our work also suggests additional components in mucus secretions, typically eliminated during mucin purification and reconstitution, may play an important role in maintaining the protective properties of mucus.

Indexed as

Cervix MucusChelating AgentsEgtazic AcidElastic ModulusFemaleHumansHydrogen-Ion ConcentrationNonoxynolParticle SizePhosphinesPolyethylene GlycolsPorosityReducing AgentsRheologyViscosityChelating AgentsEgtazic AcidNonoxynolPhosphinesPolyethylene GlycolsReducing Agentstris(2-carboxyethyl)phosphine

Identifiers

PMID24266646
PMCPMC3918948
OpenAlexW2020078193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.